Perimeter Solutions could be due for a bounce as the company capitalizes on increasing demand for fire retardant gear and its recent acquisition, according to UBS. The investment bank upgraded the manufacturer of fire safety equipment to buy from neutral. It also raised its price target on shares to $30 from $26, implying roughly 41% upside from Monday's close. Perimeter has struggled this year, l...
Perimeter Solutions could be due for a bounce as the company capitalizes on increasing demand for fire retardant gear and its recent acquisition, according to UBS. The investment bank upgraded the manufacturer of fire safety equipment to buy from neutral. It also raised its price target on shares to $30 from $26, implying roughly 41% upside from Monday's close. Perimeter has struggled this year, losing more than 22%. PRM YTD mountain PRM year to date But, "as conversations in our coverage have shifted from price/cost opportunities to volume risk, we think PRM stock could be an overlooked safe haven," analyst Joshua Spector said in a note to clients. "We see the stock sell off as overdone ... as PRM has continued to execute well and deploy cash into accretive acquisitions." A major driver of the fire safety and specialty products firm's selloff this year was a large variable compensation payment to its executives, according to UBS. But, that shouldn't continue to drive investors away from the stock. "The high water mark for future payments is near ~$28/sh (~30% upside), which we think provides enough upside to interest investors (dilution baked into our $30 PT)," Spector wrote. The analyst added that fire retardant demand is likely to grow in 2026, based on some early signs at the start of the fire season. The company is also poised to grow its services, in addition to increasing its product output due to its recently completed acquisition of Medical Manufacturing Technologies that was valued at nearly $700 million. As a result, UBS raised its EBITDA expectations for Perimeter to 5% and 9% for this year and 2027, respectively. "The business attributes seem favorable with high margins/returns, low capex , ~50% aftermarket," Spector wrote. Wall Street is split on Perimeter Solutions. Of the two analysts covering the stock, one has a hold on shares, while the other has a buy on them. Perimeter stock is down nearly 23% since the beginning of the year. However, shares are...
(RTTNews) - Poxel SA (POXEL.PA, PXXLF), a clinical-stage biopharmaceutical company, on Tuesday announced that it has agreed to sell its drug candidate PXL770 to Scynexis, Inc. (SCYX), for up to $196 million.
(RTTNews) - Poxel SA (POXEL.PA, PXXLF), a clinical-stage biopharmaceutical company, on Tuesday announced that it has agreed to sell its drug candidate PXL770 to Scynexis, Inc. (SCYX), for up to $196 million.
(RTTNews) - The Hershey Company (HSY) said, for fiscal 2026, the company continues to project: total company net sales growth in a range of 4% to 5%, organic net sales growth in a range of 2.5% to 3.5%, reported earnings per share growth of 79% to 89%, and adjusted earnings per s
(RTTNews) - The Hershey Company (HSY) said, for fiscal 2026, the company continues to project: total company net sales growth in a range of 4% to 5%, organic net sales growth in a range of 2.5% to 3.5%, reported earnings per share growth of 79% to 89%, and adjusted earnings per s
U.S. President Donald Trump speaks during the Future Investment Initiative (FII) Summit in Miami Beach, Florida, on March 27, 2026. Mandel Ngan | AFP | Getty Images President Donald Trump has warned the U.K. and France that the "U.S.A. won't be there to help you anymore," as he vented his frustration over the close allies' refusal to join military action against Iran. Posting on Truth Social , Tru...
U.S. President Donald Trump speaks during the Future Investment Initiative (FII) Summit in Miami Beach, Florida, on March 27, 2026. Mandel Ngan | AFP | Getty Images President Donald Trump has warned the U.K. and France that the "U.S.A. won't be there to help you anymore," as he vented his frustration over the close allies' refusal to join military action against Iran. Posting on Truth Social , Trump said "the Country of France wouldn't let planes headed to Israel, loaded up with military supplies, fly over French territory." "France has been VERY UNHELPFUL with respect to the "Butcher of Iran," who has been successfully eliminated! The U.S.A. will REMEMBER!!!," he said in a post Tuesday. In another post, the president singled out the U.K. for criticism. "All of those countries that can't get jet fuel because of the Strait of Hormuz, like the United Kingdom, which refused to get involved in the decapitation of Iran, I have a suggestion for you: Number 1, buy from the U.S., we have plenty, and Number 2, build up some delayed courage, go to the Strait, and just TAKE IT," he commented. "You'll have to start learning how to fight for yourself, the U.S.A. won't be there to help you anymore, just like you weren't there for us. Iran has been, essentially, decimated. The hard part is done. Go get your own oil!," he concluded. Trump has expressed his disdain for European allies that have refused to take part in the U.S. and Israel's military operation against Iran, and particularly their reluctance to get involved in what would be highly dangerous efforts to re-open the Strait of Hormuz to interntional shipping. The maritime passage has been almost completely shut by Iran, restricting global oil and gas supplies that are shipped through the strait and a number of tankers have been attacked by Iran during attempts to navigate the Iran-controlled sea route. Trump has criticized NATO allies for not assisting the U.S., telling reporters last week that he thought the military alli...
Contracts tied to US stocks advanced early Tuesday as President Donald Trump indicated he’s willing to end America’s military campaign against Iran even if the Strait of Hormuz remains largely closed. Futures tied to the S&P 500 Index rose 1% as of 7:34 a.m. in New York, while contracts on the Nasdaq 100 Index gained 0.9%. The S&P 500 closed the previous trading session less than 1% away from the ...
Contracts tied to US stocks advanced early Tuesday as President Donald Trump indicated he’s willing to end America’s military campaign against Iran even if the Strait of Hormuz remains largely closed. Futures tied to the S&P 500 Index rose 1% as of 7:34 a.m. in New York, while contracts on the Nasdaq 100 Index gained 0.9%. The S&P 500 closed the previous trading session less than 1% away from the level that places it in a technical correction, or at least 10% from its Jan. 27 peak. Crude prices rose in early trading as Iran hit a fully laden Kuwaiti oil tanker near Dubai in a drone attack. That move may have been capped in part because of a Wall Street Journal report that said Trump is willing to wind down hostilities and apply diplomatic pressure on Tehran instead. Read More: Trump Tells Allies to ‘Go Get’ Jet Fuel From Iran Via Hormuz Despite their climb, equity futures are off of the highs of overnight trading, “highlighting the paralysis created by continually shifting White House” statements, according to Andrew Tyler , head of global market intelligence at JPMorgan Chase & Co. The S&P 500 is on track to close out its worst month since 2022 as conflict in the Middle East has roiled financial markets and sent oil surging. US gasoline prices rose above $4 gallon for the first time since 2022. Energy goods and services accounted for just 3.7% of consumer spending in January compared to 5.6% before Iraq invaded Kuwait in 1990, according to data from Bank of America Corp., providing some solace that the economy “has become much more energy-efficient over time, making it more resilient to energy shocks,” BofA economist Aditya Bhave wrote in a client note. In individual movers, Whoop Inc. , the maker of popular screenless fitness bands, reached a $10.1 billion valuation, a new milestone on its way to an initial public offering. Unilever Plc said talks to sell most of its food business to McCormick & Co. are advanced and a final deal could be announced later on Tuesday...
In this article NVO NVO HIMS LLY Follow your favorite stocks CREATE FREE ACCOUNT Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images Novo Nordisk on Tuesday launched a multi-month subscription program for its Wegovy obesity drug products that aims to ensure cash-paying patients see lower, "predictable" monthly prices. Eligible patients can choose between three-, six- ...
In this article NVO NVO HIMS LLY Follow your favorite stocks CREATE FREE ACCOUNT Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images Novo Nordisk on Tuesday launched a multi-month subscription program for its Wegovy obesity drug products that aims to ensure cash-paying patients see lower, "predictable" monthly prices. Eligible patients can choose between three-, six- or 12-month subscriptions for the Wegovy injection or the two highest doses of the newly launched pill under the same brand name. Longer plans offer lower monthly pricing, and the company expects people to save up to $1,200 a year on the injection and as much as $600 a year on the pill, relative to paying for their individual dose each month, according to a Novo release. Patients can expect to pay flat monthly prices, even if they move to different doses, the company said. The subscription program will be available starting Tuesday on several of Novo's telehealth partners, including Ro, WeightWatchers, LifeMD, Sesame and Hims & Hers , with more expected to be added soon. The first-of-its-kind offering is "an opportunity to help patients not only start but stay on therapy and help them manage the ups and downs of some of the pricing considerations," regardless if they are starting treatment or are currently taking the drug, said Ed Cinca, Novo's head of marketing and patient solutions. Inability to stay on GLP-1s is a longstanding issue due to factors such as difficulty accessing the drugs and gastrointestinal side effects, with one 2025 study estimating that around 65% of patients with obesity stop treatment within a year. Wegovy subscription prices and estimated savings Injection subscription plans (0.25, 0.5, 1.7 and 2.4 milligram doses) 3-month: $329 per month, savings of $240 per year 6-month: $299 per month, savings of $600 per year 12-month: $249 per month, savings of $1,200 per year Pill subscription plans (9 and 25 milligram doses) 3-month: $289 per month, savings o...
"The Pulse With Francine Lacqua" is all about conversations with high profile guests in the beating heart of global business, economics, finance and politics. Based in London, we go wherever the story is, bringing you exclusive interviews and market-moving scoops. Today's guests: Grace Peters, JPMorgan Private Bank, Global Investment Strategy Co-Head; Silvia Viviano, UniCredit, Head of Equity Capi...
"The Pulse With Francine Lacqua" is all about conversations with high profile guests in the beating heart of global business, economics, finance and politics. Based in London, we go wherever the story is, bringing you exclusive interviews and market-moving scoops. Today's guests: Grace Peters, JPMorgan Private Bank, Global Investment Strategy Co-Head; Silvia Viviano, UniCredit, Head of Equity Capital Markets; Darya Dolzikova, RUSI, Proliferation and Nuclear Policy Senior Fellow; Diana Choyleva, Enodo Economics, Chief Economist. (Source: Bloomberg)
Shoals Technologies Group, a key player in the energy transition market, is participating in a virtual webinar hosted by Barclays, focusing on their Battery Energy Storage Systems (BESS) offerings. The event is set to feature insights from Shoals' President and BESS Product Line Manager about the company’s innovative products, market strategies, and competitive advantages in the realm of clean ene...
Shoals Technologies Group, a key player in the energy transition market, is participating in a virtual webinar hosted by Barclays, focusing on their Battery Energy Storage Systems (BESS) offerings. The event is set to feature insights from Shoals' President and BESS Product Line Manager about the company’s innovative products, market strategies, and competitive advantages in the realm of clean energy solutions. This webinar aims to provide investors and the public with a deeper understanding...
Palvella Therapeutics press release ( PVLA ): FY GAAP EPS of -$3.71 misses by $0.19 . Pro forma cash of approximately $274 million as of December 31, 2025 reflects approximate net proceeds of $215.8 million from a February 2026 equity financing; cash and cash equivalents as of December 31, 2025 were $58.0 million. More on Palvella Therapeutics Palvella Therapeutics: A Potential First-In-Class Ther...
Palvella Therapeutics press release ( PVLA ): FY GAAP EPS of -$3.71 misses by $0.19 . Pro forma cash of approximately $274 million as of December 31, 2025 reflects approximate net proceeds of $215.8 million from a February 2026 equity financing; cash and cash equivalents as of December 31, 2025 were $58.0 million. More on Palvella Therapeutics Palvella Therapeutics: A Potential First-In-Class Therapy In A Rare Dermatology Market Quant snapshot: J. Jill, AngioDynamics leads strong buys as INmune Bio, Terrestrial Energy lag Palvella Therapeutics stock rises on $200M share offering Seeking Alpha’s Quant Rating on Palvella Therapeutics Historical earnings data for Palvella Therapeutics
Tech megacaps entered a correction, oil prices broke out, big-money funds retreated and small-lot investors showed waning conviction in buying the dip. While the war in Iran that triggered all that didn’t end a three-year bull run in US equities, it is shaking it to its core. With one day to go in March, the S&P 500 Index is on track for the worst month and worst quarter since 2022. Technology sto...
Tech megacaps entered a correction, oil prices broke out, big-money funds retreated and small-lot investors showed waning conviction in buying the dip. While the war in Iran that triggered all that didn’t end a three-year bull run in US equities, it is shaking it to its core. With one day to go in March, the S&P 500 Index is on track for the worst month and worst quarter since 2022. Technology stocks were hit particularly hard, owing to a double-whammy of geopolitical angst and worries over disruption from artificial intelligence that pushed the likes of Microsoft Corp. and Adobe Inc. down at least 25% this year. For investors who witnessed the Nasdaq 100 Index fall into correction territory this month with a decline of more than 10% from its peak — and the S&P 500 not far behind — concern is high that more pain could be ahead. Fighting in Iran shows no signs of easing, while a supply shock stemming from the interruption of oil flows through the Strait of Hormuz threatens to crimp corporate profits and eat into growth. “Until this month, every dip was a buying opportunity,” Steve Sosnick , chief strategist at Interactive Brokers, said by phone. “As the month has worn on, the hope, the FOMO, the market’s willingness to rally on relatively slender pieces of news has diminished. We need something more concrete.” Below are five charts that show how the US equities market has fared over the course of the quarter. Mind the Performance Gap As anxiety about the disruptive impact of artificial intelligence mixed with uncertainty over tensions in the Middle East, investors dumped tech megacaps, the stock market’s biggest winners in 2025, in droves. That’s put the S&P 500 on track for its worst quarter relative to an equal-weight version of the gauge since 2001, when the dot-com bubble was bursting. The equal-weighted S&P 500 is down 8% from its February record and is testing a few key support levels, according to JC O’Hara , chief technical strategist at Roth Capital Partners...
(Bloomberg) -- Tech megacaps entered a correction, oil prices broke out, big-money funds retreated and small-lot investors showed waning conviction in buying the dip. While the war in Iran that triggered all that didn’t end a three-year bull run in US equities, it is shaking it to its core. With one day to go in March, the S&P 500 Index is on track for the worst month and worst quarter since 2022....
(Bloomberg) -- Tech megacaps entered a correction, oil prices broke out, big-money funds retreated and small-lot investors showed waning conviction in buying the dip. While the war in Iran that triggered all that didn’t end a three-year bull run in US equities, it is shaking it to its core. With one day to go in March, the S&P 500 Index is on track for the worst month and worst quarter since 2022. Technology stocks were hit particularly hard, owing to a double-whammy of geopolitical angst and wo
The Supreme Court found that a man had done more than harass a woman by kissing her hand as there had been "a clear sexual component" to his behaviour.
The Supreme Court found that a man had done more than harass a woman by kissing her hand as there had been "a clear sexual component" to his behaviour.
WarSec Hegseth Says "Upcoming Days Decisive" In Iran After Trump Signals Potential 'Off-Ramp' Summary WarSec Hegseth saw "upcoming days will be decisive" , strikes will continues without any deal President Trump signals off-ramp , tells world "go get your own oil", says Iran 'decimated' * * * Secretary of War Hegseth Says 'Upcoming Days Will Be Decisive', 'Damaging Iran Military Morale' WarSec Heg...
WarSec Hegseth Says "Upcoming Days Decisive" In Iran After Trump Signals Potential 'Off-Ramp' Summary WarSec Hegseth saw "upcoming days will be decisive" , strikes will continues without any deal President Trump signals off-ramp , tells world "go get your own oil", says Iran 'decimated' * * * Secretary of War Hegseth Says 'Upcoming Days Will Be Decisive', 'Damaging Iran Military Morale' WarSec Hegseth's comments were not quite a "Mission Accomplished" but definitely a reflection on the courage and completion of "systematically destroy" Iran's military capabilities. Here are Hegseth's key points (via Bloomberg): HEGSETH: VISITED TROOPS FIGHTING IN IRAN OPERATION OVER WEEKEND HEGSETH: AMERICAN FIREPOWER INCREASING, IRAN'S DECREASING HEGSETH: UPCOMING DAYS WILL BE DECISIVE HEGSETH: IRAN WILL STILL SHOOT SOME MISSILES, WE WILL SHOOT DOWN HEGSETH: OUR STRIKES DAMAGING IRAN MILITARY MORALE HEGSETH: STRIKES LEADING TO WIDESPREAD IRAN MILITARY DESERTIONS HEGSETH: REGIME CHANGE HAS OCCURRED IN IRAN HEGSETH: IF IRAN ISN’T WILLING TO MAKE DEAL, US WILL CONTINUE HEGSETH: US STRIKES WILL CONTINUE W/ MORE INTENSITY W/O DEAL Watch the feed here: * * * Off-Ramp Imminent? Trump Tells World "Go Get Your Own Oil" Via Strait After 'Decimating' Iran There's been a lot of speculation that the White House is preparing to find a 'mission accomplished' declaration moment, as 'any offramp will do' as a way to avoid a costly potential quagmire of introducing ground troops, and we may be seeing the start of one. After comments apparently leaked to The Wall Street Journal overnight that Trump is willing to leave Iran with the Strait unopened , the President has clarified his thinking in his out loud voice this morning. President Trump has posted on social media this morning, clearly signaling he is further down the road towards an off-ramp: All of those countries that can’t get jet fuel because of the Strait of Hormuz, like the United Kingdom, which refused to get involved in the decapitation o...